openPR Logo
Press release

Continuous Glucose Monitoring (CGM) Sensors Market | Size, Share and Scope Analysis to 2031

06-06-2023 06:56 AM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd

Continuous Glucose Monitoring (CGM) Sensors Market | Size,

"Global Continuous Glucose Monitoring (CGM) Sensors Market- By Trends, Industry Competition Analysis,  Covid-19 Analysis, Revenue (US$ Billions) and Forecast Till 2031." features in-depth analysis and an extensive study on the market, exploring its significant factors.

According to the market intelligence research report by InsightAce Analytic, the global Continuous Glucose Monitoring (CGM) Sensors market size was valued at US$ 4.15 Billion in 2022, and it is expected to reach US$ 17.98 Billion in 2031, recording a promising CAGR of 18% from 2023 to 2031.

Request Sample Report: https://www.insightaceanalytic.com/request-sample/1181

Diabetes is a complex, long-term illness requiring ongoing medical attention and multifaceted risk-reduction methods beyond glucose management. Diabetes is a serious health problem among the elderly; around one-quarter of individuals over 65 have Diabetes, and this number is predicted to rise dramatically in the future decades. According to the American Diabetes Association's data, Diabetes affected 34.2 million Americans in 2018, accounting for 10.5 percent of the population.

Type 1 diabetes affects almost 1.6 million Americans, including 187,000 children and adolescents. Continuous Glucose Monitoring (CGM) Sensors represents an effective approach in diabetes management for people with type 1 and type 2 diabetes a complete picture of their glucose levels at crucial times throughout the day, such as while driving, before and during exercise, taking a test, or exam, and in the middle of the night. The continuous glucose monitoring sensor provides data to either a transmitter or a recorder after measuring glucose levels in the fluid beneath the skin. Invasive (completely implanted), minimally invasive, and noninvasive sensors are the three CGM sensors types available. CGM systems have been demonstrated to assist people in maintaining stable blood glucose levels, reducing periods of low blood glucose (hypoglycemia) and high blood glucose (hyperglycemia), and lowering the risk of diabetes complications.

The market is anticipated to be driven by the factors such as an increase in the prevalence of Type 1 and Type 2 diabetes, an increase in the penetration of sensor devices, technological advancements in diabetes devices, and increased financing for Diabetes. Patients can use a continuous glucose monitoring system to improve self-management and control of their disease.

As a result, a continuous glucose monitoring device can help people with diabetes types 1, and 2 get the care they need. During the projection period, the widespread use of wearable medical devices, and developments in wireless technologies for CGM sensors, are expected to create significant growth prospects during the forecast period. Miniaturization of electrochemical-based implanted CGM devices, the emerging field of micro-and nanofabrication, is projected to offer lucrative growth opportunities during the upcoming years.

Preview for Detailed TOC: https://www.insightaceanalytic.com/report/global-continuous-glucose-monitoring-cgm-sensors-market-/1181

The COVID-19 outbreak substantially impacts Continuous Glucose Monitoring (CGM) Sensors. The COVID-19 epidemic has brought a new urgency to the need to investigate the practicality of CGM in the hospital to preserve personal protective equipment (PPE) and reduce health care workers' exposure, according to a research report published in Diabetes Care Journal in November 2020.

The players involved in the Continuous Glucose Monitoring (CGM) Sensors industry include:

Medtronics, Abbott, Senseonics, WaveForm Technologies, Inc., Advanced Biosensors-Ohio LLC, Arkal Medical, Inc., Ascensia Diabetes Care Holdings AG, Azurite Technologies, Inc., Biorasis Inc, Biovotion AG, CALISTO MEDICAL, INC., CGM3 Ltd, ConvaTec Group Plc, Cyber Medical Ltd, Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated Systems, Inc., EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, GlucoLight Corporation, Glucometrix AG, Glucosense Diagnostics Ltd, GlucoSet AS, Glucovation Inc, GluMetrics Inc, Glusense Ltd, GlySens Inc, Glysure Ltd, G-Sense Ltd., iGlyko, Inc., Indigo Diabetes NV, Innovosens AB, Insulet Corp, Integrated Medical Sensors, Integrity Applications Ltd, Invivosense ASA, I-Sens Inc, iSense Corporation, Keratin Biosciences Inc, Kiffik Biomedical inc., LEMM Technologies, LLC, Mellitor Ltd, Metronom Health Inc, mobiLIFE, Nemaura Medical Inc, Newton Photonics Inc, Orsus Medical Ltd, PKvitality, PositiveID Corp, Prediktor Medical AS, Profusa Inc, Purdue University, San Meditech (Huzhou) Co., Ltd., Senseonics Holdings Inc, SensiVida Medical Technologies, Inc., Senzime AB, Singapore Biomicro Pte Ltd, Socrates Health Solutions, Inc., Tenax Therapeutics Inc, VeriTeQ Corporation, Vytrace, Inc., and Other Prominent Players.

Key Industry Developments from Leading Players:

In May 2021, Medtronic received CE approval for the extended use of its InPen smart insulin pen for multiple daily injections (MDI) and its Guardian 4 sensor for improved diabetes control

In November 2020, Abbott announced that the FreeStyle Libre system,continuous glucose monitoring (CGM) technology, is now available for adults and children (over the age of four) living with diabetes in India, as well as women with gestational diabetes (diabetes during pregnancy), giving them the option to check glucose levels at any time.

In November 2019, WaveForm Technologies Inc.'s Cascade Continuous Glucose Monitoring (CGM) system gained CE Mark (Conformité Européenne) clearance. The product's commercialization for the European market is expected to begin in a few nations. This revolutionary technology uses a small, disposable sensor that may be worn on the body for up to 14 days to continually monitor glucose levels in interstitial fluid. The sensor and Bluetooth transmitter work together to correctly measure and transmit glucose data to the mobile app every minute, eliminating the need for a separate receiver

Continuous Glucose Monitoring (CGM) Sensors Market Regional Analysis:

North America has the highest penetration of CGM sensors on account of the early adoption of emerging technologies in the healthcare sector. The global product demand is also fueled by the rapid increase in product innovation and the growing demand for these CGM systems in diabetic management. Europe and the Asia Pacific also witness significant demand due to the presence of a diverse patient pool, developing economies, and increased collaboration between domestic and international initiatives in these regions, which are driving this industry. Because of the expansion of healthcare infrastructure in Europe and the Asia Pacific, the market for CGM sensors is expected to rise significantly.

Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1181

The Continuous Glucose Monitoring (CGM) Sensors Market Segments

The Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on Products

Noninvasive Sensing
Minimally Invasive Sensing

The Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on Sensing Technology

Enzyme Electrode
Optical Fluorescence
Others

The Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on End-users

Hospitals and Home care
Specialty Clinics
Ambulatory Settings
Others

The Global Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on Patient Population

Children and Teenagers
Adults

The Global Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on Sensor Sites

Abdomen
Upper Arm (implanted)
Back of Upper Arm
Other (Abdomen and Buttocks)

The Global Continuous Glucose Monitoring (CGM) Sensors Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2023 to 2031 based on Region

Europe
North America
Latin America (LATAM)
Asia Pacific (APAC)
Middle East & Africa (MEA)

North America Continuous Glucose Monitoring (CGM) Sensors Market Estimates Revenue (US$ Million) by Country, 2023 to 2031

U.S.
Canada

Europe Continuous Glucose Monitoring (CGM) Sensors Market Estimates Revenue (US$ Million) by Country, 2023 to 2031

Germany
France
Italy
Russia
Spain
Rest of Europe

APAC Continuous Glucose Monitoring (CGM) Sensors Market Estimates Revenue (US$ Million) by Country, 2023 to 2031

Japan
India
China
Australia & New Zealand
South Korea
Rest of Asia Pacific

LATAM Continuous Glucose Monitoring (CGM) Sensors Market Estimates Revenue (US$ Million) by Country, 2023 to 2031

Brazil
Mexico
Rest of Latin America

The Middle East & Africa Continuous Glucose Monitoring (CGM) Sensors Market Estimates Revenue (US$ Million) by Country, 2023 to 2031

GCC Countries
South Africa
Rest of the Middle East & Africa

For Customised Information @ https://www.insightaceanalytic.com/customisation/1181

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Continuous Glucose Monitoring (CGM) Sensors Market | Size, Share and Scope Analysis to 2031 here

News-ID: 3078404 • Views:

More Releases from InsightAce Analytic Pvt. Ltd

3D Printed Satellite Market expected to Witness Huge Revenue Growth to 2034
3D Printed Satellite Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 3D Printed Satellite Market- (By Component (Antenna, Bracket, Shield, Housing and Propulsion), By Satellite Mass (Nano and Microsatellite, Small Satellite, Medium and Large Satellite)), By Application, By Manufacturing Technique, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global 3D Printed Satellite Market is valued
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market expected to Witness Huge Revenue Growth to 2034
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market expect …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market- (By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market is expected to
Health and Wellness Market expected to Witness Huge Revenue Growth to 2034
Health and Wellness Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Health and Wellness Market- (By Sector (Personal Care & Beauty & Anti-Aging, Nutrition & Weight Loss, Physical Activity, Wellness Tourism, Preventive & Personalized Medicine, Spa Economy, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Health and Wellness Market is valued at
Blood Plasma Freezers Market expected to Witness Huge Revenue Growth to 2034
Blood Plasma Freezers Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood Plasma Freezers Market- (By Type (Manual Defrost, Automatic Defrost), By Application (Hospital, Laboratory), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Blood Plasma Freezers Market is valued at US$ 539.6 Mn in 2023, and it is expected to reach US$ 772.0 Mn

All 5 Releases


More Releases for CGM

Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions. Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention. In 2017, National Diabetes Services Scheme (NDSS) initiated by
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12                   CMA CGM
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market. The global CGM market is undergoing a